Harpreet Dhaliwal
Corporate Officer/Principal at VAXCYTE, INC.
Net worth: 1 M $ as of 29/04/2024
Network origin in Harpreet Dhaliwal first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Biotechnology | 24 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Harpreet Dhaliwal via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Investor Relations Contact Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Juvaris BioTherapeutics, Inc.
Juvaris BioTherapeutics, Inc. BiotechnologyHealth Technology Juvaris BioTherapeutics, Inc. develops novel, adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer. The company was founded by Martin D. Cleary, Jeff Fairman and Steven W. Dow in February 2003 and is headquartered in Burlingame, CA. | Biotechnology | Chief Executive Officer Founder | |
CARGO THERAPEUTICS, INC. | Biotechnology | Director/Board Member General Counsel | |
Santa Clara University | College/University | Masters Business Admin Undergraduate Degree | |
STANDARD BIOTOOLS INC. | Medical Specialties | Corporate Officer/Principal Chairman | |
University of California, Davis | College/University | Corporate Officer/Principal Undergraduate Degree | |
DERMIRA, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Infectious Diseases Society of America
Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services The Infectious Diseases Society of America is a non-profit company that provides clinical practice guidelines development and guideline panelists for infectious diseases. The company is based in Arlington, VA and has subsidiaries in the United States. The company specializes in antimicrobial stewardship and have established Antimicrobial Stewardship Centers of Excellence. The CEO of the company is Christopher Busky. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Celera Diagnostics LLC
Celera Diagnostics LLC Medical/Nursing ServicesHealth Services Celera Diagnostics LLC discovers, develops and commercializes molecular diagnostics. The firm enables physicians to diagnose, monitor and treat disease. It manufactures products for infectious disease testing and for genetic conditions such as cystic fibrosis. The company was founded in 2001 by Kathy Ordoñez and is headquartered in Alameda, CA. | Medical/Nursing Services | Corporate Officer/Principal | |
Applied Biosystems, Inc.
Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Medical Specialties | Corporate Officer/Principal | |
Colby Pharmaceutical Co.
Colby Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Colby is transitioning to a clinical stage drug development company. The company was launched as a Wisconsin Alumni Research Foundation (WARF) spin-out and is strategically aligned with leading clinicians and drug discovery scientists at the University of Wisconsin Paul P. Carbone Comprehensive Cancer Center (UWCCC). Colby is accessing data from funded grants and private investment to develop its therapeutic drugs for therapy-resistant and hypoxic conditions. Colby's lead drugs have unique mechanisms of action and target specific pathways. The company is focused on clinical development of its lead drugs, CPC-100 and -200, in patients with recurrent PCa and other solid tumors, respectively. In 2010, Colby plans to launch a Phase I/IIa study of CPC-100 in men with PCa who fail Androgen Depletion Therapy, as evidenced by rising PSA levels. CPC-200 is being scheduled for a Phase I/IIa in men with high-risk tumors. Colby's two pipeline drugs, CPC-300 and CPC-410 for therapy-resistant metastatic and hypoxic tumors are in late pre-clinical development and are funded by federal grants, including an awarded Colby SBIR grant and by private investors. The Company has demonstrated safety of its lead drugs following efficacy studies in rodents and toxicology studies in mice, rats, and dogs. | Pharmaceuticals: Major | Corporate Officer/Principal | |
The University of Arkansas | College/University | Doctorate Degree | |
The American Association of Immunologists | Corporate Officer/Principal | ||
Syracuse University | College/University | Undergraduate Degree | |
Northwest Missouri State University | College/University | Undergraduate Degree | |
CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
IO BIOTECH, INC. | Biotechnology | Chairman | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | General Counsel | |
Massachusetts Bar Association
Massachusetts Bar Association Miscellaneous Commercial ServicesCommercial Services The Massachusetts Bar Association is a non-profit organization that serves the legal profession and the public by promoting the administration of justice, legal education, professional excellence, and respect for the law. The MBA is based in Boston, MA. The organization offers various membership advantages, volunteer opportunities, and educational resources such as CLE programs, practicing with professionalism courses, and publications like the ejournal and Lawyers Journal. The MBA also provides advocacy services, public resources, and exclusive benefits to its members such as the Lawyer Referral Service, Insurance Agency, and MBA On Demand. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Tufts University | College/University | Undergraduate Degree | |
IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Administrative Officer | |
Skadden, Arps, Slate, Meagher & Flom LLP
Skadden, Arps, Slate, Meagher & Flom LLP Miscellaneous Commercial ServicesCommercial Services Skadden, Arps, Slate, Meagher & Flom LLP provides legal advisory services. Its practice areas include mergers and acquisitions, finance, litigation, corporate finance, insurance, tax, labor and employment, political law, private equity, corporate, antitrust, white collar crime, international, regulatory, and legislation. The company was founded by Marshall Skadden, John Slate, and Les Arps in 1948 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Northwestern University School of Law | College/University | Graduate Degree | |
Greater Boston Legal Services, Inc.
Greater Boston Legal Services, Inc. Miscellaneous Commercial ServicesCommercial Services Greater Boston Legal Services, Inc. provides free civil legal assistance to low-income people. It offers advice and represent people in court, before agencies, and before city councils and the state legislature. The company was founded in 1976 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Allergy Amulet, Inc.
Allergy Amulet, Inc. Electronic Equipment/InstrumentsElectronic Technology Allergy Amulet, Inc. manufactures food allergen detection device. The firm enables mobile measurements to help individuals avoid ingesting target allergens The company was founded by Abigail Barnes and Joseph BelBruno and is headquartered in Madison, WI. | Electronic Equipment/Instruments | Director/Board Member | |
CYTOMX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
ARCUTIS BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Enterome SA
Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member | |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Acrigen Biosciences, Inc.
Acrigen Biosciences, Inc. BiotechnologyHealth Technology Acrigen Biosciences, Inc. operates as a early-stage life science gene editing company. The company was founded by Joseph Bondy-Denomy in 2019 and is headquartered in Kensington, CA. | Biotechnology | Director/Board Member | |
TPG Biotech
TPG Biotech Investment ManagersFinance TPG Biotech (TPG biotech) is a venture capital firm, a subsidiary of TPG Capital Advisors LLC founded in 2002. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
Verax Biomedical, Inc.
Verax Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Verax Biomedical, Inc. develops rapid tests for detecting bacterial contaminants in blood cells and tissues. The firm's first target application for its technology is to test for the presence of bacterial contaminants in platelets and bacterial contaminants in platelets and red blood cells represent the greatest lethal infectious risks in transfusion medicine today and no rapid, simple methods are presently available to effectively address this threat. Verax Biomedical was founded by Joe R. Sanders and Joe L. Straight in 1999 and is headquartered in Marlborough, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Engage Therapeutics, Inc.
Engage Therapeutics, Inc. BiotechnologyHealth Technology Engage Therapeutics, Inc. engages in the development of rescue therapy for uncontrolled epileptic seizures. The company was founded by Gregory T. Mayes III and Jouko Isojarvi in 2017 and is headquartered in Summit, NJ. | Biotechnology | Chairman | |
Halo Neuro, Inc.
Halo Neuro, Inc. Packaged SoftwareTechnology Services Halo Neuro, Inc. develops neuroscience based technology. It offers its products under the categories of fitness, sports, gaming, health, biotech, wearables and other consumer technology. The company was founded by Brett Wingeier, Amol R. Sarva, Lee M. von Kraus and Daniel S. Chao in 2013 and is headquartered in San Francisco, CA. | Packaged Software | Director/Board Member | |
Viewpoint Therapeutics, Inc.
Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Viewpoint Therapeutics, Inc. operates as a biotechnology company. It prevents and treats cataracts and presbyopia, and protein misfolding. The company was founded by Leah Makley in July of 2014 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
Lagunita Biosciences LLC
Lagunita Biosciences LLC Investment ManagersFinance Lagunita Biosciences LLC (Lagunita Biosciences) is a venture Capital firm founded in 2015 by Mark S. Blumenkranz. The firm is headquartered in Menlo Park, California. | Investment Managers | Director/Board Member | |
SATSUMA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Ceribell, Inc.
Ceribell, Inc. Medical SpecialtiesHealth Technology Ceribell, Inc. engages in the development of diagnosis medical devices. The firm focuses on making electroencephalography (EEG) for diagnosis and treatment of patients at risk for seizures. Its products include Ceribell EEG headband, Ceribell EEG recorder, and spot-checks with brain stethoscope. The company was founded by Jane Chao, Josef Parvizi and Chris Chafe in 2014 and is headquartered in Mountain View, CA. | Medical Specialties | Director/Board Member | |
Red Tree Venture Capital
Red Tree Venture Capital Investment ManagersFinance Red Tree Venture Capital is a venture capital firm founded by Heath Lukatch. The firm is headquartered in portola, California. | Investment Managers | Founder | |
DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Corporate Officer/Principal | |
SI-BONE, INC. | Medical Specialties | Corporate Officer/Principal | |
Virsti Therapeutics, Inc. | Chief Executive Officer |
Statistics
International
United States | 48 |
Denmark | 2 |
Brazil | 2 |
France | 2 |
Sectoral
Health Technology | 30 |
Consumer Services | 8 |
Commercial Services | 7 |
Finance | 4 |
Health Services | 2 |
Operational
Director/Board Member | 91 |
Corporate Officer/Principal | 81 |
Independent Dir/Board Member | 35 |
Undergraduate Degree | 18 |
Chairman | 14 |
Most connected contacts
Insiders | |
---|---|
Heath Lukatch | 43 |
Kurt von Emster | 34 |
K. Hirth | 18 |
Anne Drapeau | 17 |
Halley Gilbert | 17 |
Mark Wiggins | 15 |
Michael Kamarck | 15 |
Teri Loxam | 14 |
Carlos Paya | 14 |
Jane Wright-Mitchell | 14 |
Jeff Fairman | 13 |
Andrew Guggenhime | 13 |
Elvia Cowan | 11 |
Paul Sauer | 8 |
James Wassil | 8 |
- Stock Market
- Insiders
- Harpreet Dhaliwal
- Company connections